The Statement of Objections is addressed to the following entities: Servier SAS, Les Laboratoires Servier, Servier Laboratories Limited, Adir, Biogaran (all belonging to the Servier group), Teva Pharmaceuticals Industries Limited, Teva Pharmaceuticals Europe BV, and Teva UK Limited (belonging to the Teva group), Unichem Laboratories Limited and its subsidiary, Niche Generics Limited, Mylan Incorporated and its subsidiary, Mylan Laboratories Limited (previously Matrix), Krka, d.d. Novo mesto, and Lupin Limited.
Les entreprises suivantes sont destinataires de la communication des griefs: Servier SAS, Les Laboratoires Servier, Servier Laboratories Limited, Adir, Biogaran (appartenant toutes au groupe Servier), Teva Pharmaceuticals Industries Limited, Teva Pharmaceuticals Europe BV, et Teva UK Limited (appartenant au groupe TEVA), Unichem Laboratories Limited et ses filiales, Niche Generics Limited, Mylan Incorporated et sa filiale, Mylan Laboratories Limited (anciennement Matrix), Krka, d.d., Novo mesto, et Lupin Limited.